© 2004 by BMJ Publishing Group & British Cardiac Society
EDITORIAL
Practising what is preached: the MINAP study
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
Correspondence to:
Correspondence to:
Professor Harvey White
Green Lane Cardiovascular Service, Auckland, City Hospital, Private Bag 92189, Auckland 1030, New Zealand; harveyw@adhb.govt.nz
Many patients with acute coronary syndromes do not receive evidence based treatments, and treatment standards vary significantly within and between countries
Abbreviations: ACS, acute coronary syndromes; ACE, angiotensin converting enzyme; ACS, acute coronary syndromes; EUROASPIRE, European Action on Secondary and Primary Prevention Through Intervention to Reduce Events; GRACE, Global Registry of Acute Coronary Events; MINAP, Myocardial Infarction National Audit Project; LDL, low density lipoprotein; NRMI, National Registry of Myocardial Infarction; PROVE-IT–TIMI-22, Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22
Keywords: acute myocardial infarction; registries; secondary prevention; acute coronary syndromes
| The first 150 words of the full text of this article appear below. |
Over the past two decades, findings from randomised controlled trials have revolutionised the treatment of patients with acute coronary syndromes (ACS). Clinical practice guidelines have been drawn up nationally and internationally to integrate the vast wealth of trial findings into up-to-date, clinically relevant treatment strategies.1–4 So can patients who present to their local hospital with an ACS be assured that the treatment they receive is appropriate, evidence based, and in accordance with current guidelines? Studies worldwide have found that they cannot,5,6 and that few doctors perform consistently as well as they should. Many of us do not practise what we preach.
Findings from registries and large randomised clinical trials show that many patients with ACS do not receive evidence based treatments, and that treatment standards vary significantly within and between countries.5,6 It is therefore remarkable to read the report from the Myocardial Infarction National Audit Project (MINAP),7 published in this
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
